Pan-European monitoring of susceptibility to human-use antimicrobial agents in enteric bacteria isolated from healthy food-producing animals

Objectives To determine the antimicrobial susceptibility of Escherichia coli, Salmonella, Campylobacter and Enterococcus from cattle, pigs and chickens across the European Union (EU) using uniform methodology. Methods Intestinal samples (1624) were taken at slaughter across five EU countries. Bacter...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 2012-03, Vol.67 (3), p.638-651
Main Authors: de Jong, Anno, Thomas, Valérie, Simjee, Shabbir, Godinho, Kevin, Schiessl, Brigitte, Klein, Ulrich, Butty, Pascal, Vallé, Michel, Marion, Hervé, Shryock, Thomas R.
Format: Article
Language:English
Subjects:
Abattoirs
Animals
Anti-Infective Agents - pharmacology
Antibiotics
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacterial diseases
Bacterial diseases of the digestive system and abdomen
Biological and medical sciences
Campylobacter coli
Campylobacter jejuni
Cattle
Chickens
E coli
Enterobacteriaceae - drug effects
Enterobacteriaceae - isolation & purification
Enterococcus
Enterococcus faecium
Epidemiology
Escherichia coli
European Union
Food safety
Human bacterial diseases
Infectious diseases
Intestines - microbiology
Medical sciences
Microbial Sensitivity Tests
Pharmacology. Drug treatments
Salmonella
Swine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives To determine the antimicrobial susceptibility of Escherichia coli, Salmonella, Campylobacter and Enterococcus from cattle, pigs and chickens across the European Union (EU) using uniform methodology. Methods Intestinal samples (1624) were taken at slaughter across five EU countries. Bacteria were isolated in national laboratories, whilst MICs were determined in a central laboratory for key antimicrobials used in human medicine. Clinical resistance was based on CLSI breakpoints and decreased susceptibility based on European Food Safety Authority (EFSA)/EUCAST epidemiological cut-off values. Results Isolation rates were high for E. coli (n = 1540), low for Salmonella (n = 201) and intermediate for Campylobacter (n = 940) and Enterococcus (n = 786). For E. coli and Salmonella, clinical resistance to newer compounds (cefepime, cefotaxime and ciprofloxacin) was absent or low, but decreased susceptibility was apparent, particularly in chicken strains. Resistance to older compounds (except gentamicin) was variable and higher. Colistin resistance was absent for E. coli, but apparent for Salmonella. For Campylobacter jejuni, ciprofloxacin resistance was markedly prevalent for chickens, whereas clinical resistance and decreased susceptibility to erythromycin was absent or very low. For Campylobacter coli, resistance was notably higher. None of the Enterococcus faecium strains was resistant to linezolid, but some were resistant to ampicillin or vancomycin. Resistance to quinupristin/dalfopristin was frequent. Conclusions Resistance patterns varied widely depending on bacterial species, antibiotics, hosts and region. Resistance varied among countries, particularly for older antimicrobials, but clinical resistance to newer antibiotics used to treat foodborne disease in humans was generally very low. In the absence of resistance to newer compounds in E. coli and Salmonella, the apparent decreased susceptibility should be monitored.
ISSN:0305-7453
1460-2091
DOI:10.1093/jac/dkr539